TickerFacts.

Renalytix plc (RNLXY): Cost of Revenue

Annual figures by period end, from SEC filings.

Not updated since 2024-06-30. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.

$2.13M
Year ended 2024-06-30
+35.5%
3-year compound annual growth
$2.68M2020-06-30: $02021-06-30: $858.0K2022-06-30: $2.10M2023-06-30: $2.68M2024-06-30: $2.13M$2.13M
2020-06-30 Cost of Revenue (USD) 2024-06-30
Period endedCost of RevenueChange YoYSource filing
2024-06-30$2.13M-20.5%2024-09-30, From 2023-07-01
2023-06-30$2.68M+28.0%2024-09-30, From 2022-07-01
2022-06-30$2.10M+144.3%2023-09-28, From 2021-07-01
2021-06-30$858.0Kn/a2022-10-31, From 2020-07-01
2020-06-30$0n/a2022-10-31, From 2019-07-01